跳至主要内容
临床试验/NCT02537249
NCT02537249已完成不适用

Effects of Dexmedetomidine on Quality of Recovery and Analgesia After Video-assisted Thoracoscopic Surgery

Yonsei University1 个研究点 分布在 1 个国家目标入组 111 人开始时间: 2015年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
111
试验地点
1
主要终点
quality of recovery measured by QoR-40 questionnaire

研究概览

简要总结

Dexmedetomidine is a selective α2 adrenergic agonist that can be considered analgesics, anxiolytic,and anti-stress effect . This randomized, double-blind placebo-controlled trial of intraoperative dexmedetomidine for improvement of quality of recovery and analgesia from surgery. Patients scheduled to undergo video-assisted thoracoscopic surgery (VATS) will be enrolled. Patients will be recruited before the date of their surgery and will complete the Quality of Recovery-40 (QoR-40) questionnaire before their surgery and at 24 and 48 hours post op. They will also complete clinically significant pains score and oxygenation from the postanesthetic recovery unit (PACU).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
盲法
Double (Participant, Investigator)

入排标准

年龄范围
20 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The inclusion criteria included patients scheduled video-assisted thoracoscopic surgery for lung cancer
  • Adults above 20 years of age and providing informed consent.
  • American Society of Anesthesiologists (ASA) Physical class II, & III patients

排除标准

  • severe functional liver or kidney disease
  • history of chronic pain requiring opioid treatment
  • arrhythmia or received treatment with antiarrythmic drug .
  • severe bradycardia (HR < 45 bpm) and AV block
  • pathologic esophageal lesion (esophageal stricture or varix )
  • psychiatric/central nervous system disturbance that would preclude completion of the QoR-40 questionnaire
  • History of alcohol or drug abuse

研究组 & 干预措施

Dexmedetomidine

Experimental

干预措施: Dexmedetomidine (Drug)

Saline 0.9%

Sham Comparator

干预措施: Normal saline (Drug)

结局指标

主要结局

quality of recovery measured by QoR-40 questionnaire

时间窗: 24 hr after operation

pulmonary function test

时间窗: 24 hr after operation

postoperative lung function assessed by spirometry

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验